Investigator
Karolinska Institutet, Department of Biosciences and Nutrition
ERβ in Granulosa Cell Tumors and Its Clinical Potential
Abstract Granulosa cell tumors (GCTs) are rare ovarian tumors comprising an adult and a juvenile subtype. They have a generally good prognosis, but the survival rate drastically declines in patients with late-stage or recurring tumors. Due to the rarity of GCTs, the tumor type is largely understudied and lacks a specific treatment strategy. Estrogen receptor beta (ERβ/ESR2) has been found to be highly expressed in GCTs, which could be of therapeutic importance since it can be targeted with small molecules. However, its role in GCTs is not known. In this review, we summarize the current knowledge about the action of ERβ in the ovary and discuss its prospective role in GCTs.
Researcher
Karolinska Institutet · Department of Biosciences and Nutrition
KTH Royal Institute of Technology
Visiting Professor
Karolinska Institutet · Biosciences and Nutrition
Professor
KTH Royal Institute of Technology · School of Biotechnology
Associate Professor
University of Houston · Biology and Biochemistry
Senior Scientist
Ph.D.
KTH Royal Institute of Technology · Biotechnology and Biochemistry
SE